Full-Time

Associate Director

QA Computer Systems Validation

Posted on 8/13/2024

Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

51-200 employees

Develops RNAi-based therapies for diseases

Biotechnology
Healthcare

Compensation Overview

$150k - $190kAnnually

Expert

Fitchburg, WI, USA + 1 more

More locations: San Diego, CA, USA

Category
QA & Testing
Manual Testing
Quality Assurance
Requirements
  • At least 10 years of relevant experience
  • Experience leading QA CSV in the pharmaceutical industry and quality organization
  • Experience in EDMS, LMS, e-QMS and ERP implementation and lifecycle management
  • Experience as an effective collaborator and leader
  • Experience creating policies and procedures focused on data integrity and computer systems validation
  • Experience creating and presenting project plans, trainings and other presentations for leadership
  • Strong knowledge of 21CFRPart 11/Annex 11/GAMP regulations, associated guidances, and standards
  • Competent knowledge of Microsoft Office, EDMS, eQMS, LMS, ERP suites
Responsibilities
  • Serve as an internal subject matter expert in the field of CSV/CSA and 21 CFR Part11/Annex 11 /GAMPfor GxP regulated industry and advise internal stakeholders and management on matters related to regulatory compliance and R&D electronic data integrity
  • Collaborate with business partners to ensure continuous and verifiable compliance and data integrity throughout the entire information systems ecosphere and lifecycle
  • Coordinate Quality input in the development and revision of GxP computer system procedures, change control, investigations and CAPAs related to the computerized systems.
  • Assess and ensure overall readiness of the CSV/CSA program and computer-related systems readiness for audits and regulatory inspections
  • Work in collaboration with the ISI and system owners to prioritize, develop and implement necessary risk assessments and mitigation actions, aligned with evolving regulatory requirements, industry standards, and business initiatives and strategies through the system lifecycle -implementation, maintenance, change management, and decommissioning
  • Coordinate Quality review and approval of validation strategy, plans, protocols, reports and other verification/validation related documentation for GxP computer systems
  • Collaborate with ISI and business partners on development of robust policies and other guidance documents to ensure compliance with applicable laws and regulations, and industry standards
  • Proactively drive culture of compliance by drafting and disseminating written materials and training that are aimed at increasing stakeholders’ awareness and understating of relevant regulatory requirements and industry standards.
  • Prepare and present periodic reports and status of compliance to management, including the measures and activities to ensure compliance.
  • Effectively manage priorities, multiple projects and ability to communicate with all levels of personnel
  • Other duties as assigned
Arrowhead Pharmaceuticals

Arrowhead Pharmaceuticals

View

Arrowhead Pharmaceuticals develops medicines aimed at treating severe diseases by targeting and silencing specific genes. The company uses RNA interference (RNAi), a natural process that reduces gene expression, to create therapies that can potentially stop or reverse diseases like cystic fibrosis and hepatitis B. Their approach involves a variety of RNA chemistries and effective delivery methods to ensure that the target genes are significantly reduced in activity. Unlike many competitors, Arrowhead focuses specifically on RNAi-based therapies, which allows them to address medical needs that are not met by existing treatments. The goal of Arrowhead Pharmaceuticals is to provide new treatment options for patients suffering from genetic disorders, leveraging their expertise and partnerships to bring these therapies to market.

Company Stage

IPO

Total Funding

$4.7M

Headquarters

Pasadena, California

Founded

2004

Simplify Jobs

Simplify's Take

What believers are saying

  • Arrowhead secured a $500 million facility with Sixth Street for pipeline advancement.
  • Positive Phase 2 data for plozasiran shows promise in treating severe hypertriglyceridemia.
  • Collaboration with Sarepta Therapeutics brings significant financial and research benefits.

What critics are saying

  • Increased competition from companies like Alnylam Pharmaceuticals in the RNAi space.
  • Potential regulatory scrutiny could delay clinical trials for RNAi therapies.
  • Financial instability risk due to reliance on strategic financing agreements.

What makes Arrowhead Pharmaceuticals unique

  • Arrowhead uses RNAi to target and silence disease-causing genes effectively.
  • The company has a broad portfolio of RNA chemistries for diverse therapeutic applications.
  • Arrowhead's strategic partnerships enhance its research and development capabilities.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

401(k) Retirement Plan

Paid Vacation

Paid Sick Leave

INACTIVE